GLUCAGON SECRETION IN WELL CONTROLLED DIABETES MELLITUS

糖尿病控制良好时的胰高血糖素分泌

• 批准号: 6414480
• 负责人: PHILIP RASKIN
• 金额: $ 32.14万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-12-01 至 2001-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6414480
• 关键词: basement membrane; biomarker; capillary; clinical research; diabetes mellitus; diabetes mellitus therapy; diabetic angiopathy; glucagon; human subject; human therapy evaluation; insulin sensitivity /resistance; secretion; striated muscles

Aims are: 1) to evaluate the relationship between the level of antecedent diabetic control & development of small blood vessel complications; 2) to use skeletal muscle capillary basement membrane width as a marker for diabetes complications; 3) to use alternate methods of treating insulin dependent and non-insulin dependent diabetes mellitus; 4) to study insulin resistant diabetes mellitus.

目的是：1）评估水平之间的关系， 糖尿病前期控制和小血管发育 并发症; 2）使用骨骼肌毛细血管基底膜 宽度作为糖尿病并发症的标志; 3）使用交替 治疗胰岛素依赖型和非胰岛素依赖型糖尿病的方法 研究胰岛素抵抗型糖尿病。